Enliven Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Enliven Therapeutics, Inc.
CIK #0001672619
EDGAR Form CIK 2011 - 2026
10-K [0001672619]
10-Q [0001672619]
3 [0001672619]
4 [0001672619]
8-K [0001672619]
D [0001672619]
SC 13D [0001672619]
SC 13G [0001672619]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vestal Point Capital LP Enliven Therapeutics Inc [2026-02-17]
Polar Capital Holdings PLC Enliven Therapeutics Inc [2025-08-14]
Polar Capital Holdings PLC Enliven Therapeutics Inc [2024-11-13]
BlackRock Inc Enliven Therapeutics Inc [2024-11-08]
BlackRock Inc Enliven Therapeutics Inc [2024-10-24]
FMR LLC Enliven Therapeutics Inc [2023-05-10]
Fairmount Funds Management LLC Enliven Therapeutics Inc [2023-04-27]
Commodore Capital LP Enliven Therapeutics Inc [2023-04-24]
Venrock Healthcare Capital Partners III LP Enliven Therapeutics Inc [2023-03-13]
Citadel Advisors LLC Enliven Therapeutics Inc [2023-03-06]
View All
Form 3/4/5 Subject 2011 - 2026
Kunkel Lori Anne
Enliven Therapeutics, Inc.
OrbiMed Genesis GP LLC
OrbiMed Advisors LLC
OrbiMed Capital GP VII LLC
Hohl Benjamin
Collins Helen Louise
Heyman Richard A.
Lyssikatos Joseph P
Patel Anish
View All
Terms | Privacy | Providers | Guide
tony@aum13f.com